Our weekly selection of the TOP news about Lithuania (25-01-17)
We invite you to check out our weekly selection of the TOP news about Lithuania:
A team of scientists from the Institute of Biotechnology at Vilnius University Life Sciences Centre (VU GMC) has made a significant contribution to the understanding of bacterial defence mechanisms. Led by PhD researchers Dr. Dalia Smalakytė, Audronė Rukšėnaitė, Giedrius Sasnauskas, Dr. Giedrė Tamulaitienė, and Dr. Gintautas Tamulaitis, the group has uncovered the structure and function of the CRISPR-Cas “protein scissors” found in bacteria. Their findings have been published in the prestigious journal Molecular Cell under the title “Filament Formation Activates Protease and Ring Nuclease Activities of CRISPR Lon-SAVED.
By cleverly focusing on sectors with a high level of global exposure, such as fintech and film production, the Lithuanian capital Vilnius remains firmly in the sights of international location experts.
The Gas Transmission System Operators (TSOs) of Finland, Estonia, Latvia, Lithuania, Poland, and Germany's Ontras have successfully completed a pre-feasibility study of the Nordic-Baltic Hydrogen Corridor (NBHC). This significant study, initiated in January 2024, defines the key conditions for implementing the NBHC, aimed at transporting renewable hydrogen between the six countries.
Dexcom Expands Operations in Lithuania with New Clinical Affairs Team (Invest Lithuania)
Dexcom, a global leader in continuous glucose monitoring (CGM) technology, is expanding its Clinical Affairs team to Lithuania. The expansion reflects the company’s commitment to broadening its clinical research efforts within Europe. The new hires will join Dexcom’s 500-strong team at the company’s Global Business Services hub in Vilnius.
See you next time!
Permanent Representation of Lithuania to the European Union
Our social media accounts in English
